Compliance
Bormioli Pharma intends to guarantee its customers the highest standard of professional competence, also in terms of quality, integrity and ethical conduct. In this section you can find the Group's main Ethics and Compliance documents, as well as the Sustainability Reports and the Corporate Policy for Safety and the Environment.
Organisational Model 231 and Code of Ethics
Bormioli Pharma S.p.A. has adopted an Organisational, Management and Control Model in compliance with Legislative Decree no. 231 of 2001 with the aim of ensuring that all parts of the company act with integrity and transparency in all activities and relations with public or private entities and individuals.
The task of supervising the adequacy, effectiveness and proper functioning of the Model is assigned to the Supervisory Board.
Bormioli Pharma S.p.A. guarantees the possibility of reporting, in a completely confidential manner, potential unlawful acts relevant for the purposes of Leg. 231/2001 through the following channels:
-integrity line' platform;
- e-mail address: organismo.vigilanza@bormiolipharma.com;
- ordinary mail to the address "Viale Giovanni Falcone n.48/A, Parma, 43122 - Italy" indicating as the addressee "Supervisory Body".
The Bormioli Pharma Group has a Code of Ethics, which is an integral and substantial part of the Organisation, Management and Control Model and gathers the ethical principles and rules of conduct in which the Bormioli Pharma Group is mirrored, defining the general discipline which all those who operate within the company are subject to.
Anti-Corruption Procedure
The Bormioli Pharma Group conducts its business with loyalty, fairness, honesty, integrity and transparency.
This procedure is inspired by the principles of conduct set out in the Organisation, Management and Control Model adopted by the Company pursuant to Legislative Decree no. 231 of 8 June 2001 and in the relevant Bormioli Pharma Code of Ethics, constituting a Compliance Standard and being a prescriptive document, applicable to all processes of the Bormioli Pharma Group, which aims to provide all the Group's staff with clear and transparent rules to be followed to ensure compliance with anti-bribery and corruption regulations.
Antitrust Guidelines
The corporate culture of Bormioli Pharma S.p.A. is based on the principles of free competition ("Bormioli" or the "Company"). In the performance of their work, Bormioli's employees are therefore required to fully comply with antitrust law.
The Bormioli Pharma Group adopted an Antitrust Conduct Handbook whichconstitutes a consultation tool for the use and benefit of its employees who, on Bormioli's behalf, have relations with competitors, customers, suppliers and other stakeholders, in order to identify, in advance and effectively, independently or with the assistance of the Compliance Officer, conducts that could violate competition law.
Whistleblowing
Group.
The reports in question can be made by employees, collaborators and third parties through a dedicated portal, available at the following link: https://bormiolipharma.integrityline.com.
The EQS Integrity Line portal intends to provide any subject, including customers and suppliers, with the opportunity to send reports, also in anonymous form, concerning behaviours, risks, offences or irregularities, executed or attempted, to the detriment of the interests of the Bormioli Pharma Group, or, in any case, liable to violate the Model and the Code of Ethics.
More information can be found in the Bormioli Pharma Group Whistleblowing Policy.
Sustainability and Quality
Como proveedor de envases para uso farmacéutico, nos esforzamos por ofrecer soluciones que tengan un efecto positivo en el bienestar de las personas y en el futuro de nuestro planeta. Para ello, hemos elaborado y firmado una serie de documentos que reafirman los principios, los objetivos y las normas de conducta que inspiran la cultura y la forma de hacer negocios del Grupo.
A través de la «Política y Gobernanza ASG», identificamos los objetivos de desarrollo sostenible de Bormioli Pharma, que son coherentes con algunos de los ODS de la Agenda 2030 de la ONU, y definimos las estructuras y procesos que se aplicarán para alcanzarlos. Por último, con el «Informe de Sostenibilidad» medimos y comunicamos a nuestros grupos de interés nuestras actividades y resultados en relación con nuestros objetivos.
La «Política Corporativa sobre Derechos Humanos» define los principios y los compromisos asumidos por Bormioli Pharma para la protección y la promoción de los derechos humanos. Estos derechos, ya establecidos en el Código Ético, están en el núcleo de nuestra cultura corporativa y deben considerarse un elemento fundamental para gestionar nuestro negocio de forma responsable y, al mismo tiempo, contribuir al bienestar de la comunidad en la que operamos.
El documento «Política Corporativa de Seguridad y Medio Ambiente» recoge los criterios que nos guían en la gestión de los procedimientos de Calidad, Seguridad y Medio Ambiente, los mismos que se describen en las normas ISO 9001, ISO 15378, ISO 13485, ISO 45001 e ISO 14001. Para garantizar el cumplimiento de estos criterios, nuestros sistemas se auditan periódicamente por organismos de certificación independientes a escala internacional.